about
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesNew insights into coupling and uncoupling of cerebral blood flow and metabolism in the brainPathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative productsBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeInflammatory responses in hypoxic ischemic encephalopathyCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsInterleukin-6 mediates enhanced thrombus development in cerebral arterioles following a brief period of focal brain ischemia.Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial CellsOxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies.Prophylactic Chronic Zinc Administration Increases Neuroinflammation in a Hypoxia-Ischemia ModelAttenuated inflammatory response in aged mice brains following strokeEpidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injuryCold-inducible RNA-binding protein mediates neuroinflammation in cerebral ischemia.Ischemia as a possible effect of increased intra-abdominal pressure on central nervous system cytokines, lactate and perfusion pressures.Reactive microglia and macrophage facilitate the formation of Müller glia-derived retinal progenitors.Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke.Overexpression of mitochondrial uncoupling protein 2 inhibits inflammatory cytokines and activates cell survival factors after cerebral ischemia.Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy.Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice.Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signalingAnti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial CellsRelevance of distinct monocyte subsets to clinical course of ischemic stroke patientsInterleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism.Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in miceRole of cell adhesion molecules in acute ischemic stroke.Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events.Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury.Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus3,4,5-Trihydroxycinnamic Acid Inhibits LPS-Induced iNOS Expression by Suppressing NF-κB Activation in BV2 Microglial CellsMicroarray Profiling and Co-Expression Network Analysis of LncRNAs and mRNAs in Neonatal Rats Following Hypoxic-ischemic Brain DamageTumour necrosis factor alpha, ınterleukin 10 and ınterleukin 6 gene polymorphisms of ıschemic stroke patients ın south Marmara region of Turkey.Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke.Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegenerationN-Palmitoylethanolamine Prevents the Run-down of Amplitudes in Cortical Spreading Depression Possibly Implicating Proinflammatory Cytokine Release.3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration
P2860
Q26740083-901E5963-D1A2-4553-B4E9-33C64CFE8925Q26745457-C3172EA9-9337-4558-9826-769FCE772A7CQ26777643-404860B9-F1E6-4A00-A31C-27579509A0D3Q26864317-17F93AC9-EABD-48BD-8C70-AF3BE21F6083Q27001711-E92FBE99-0D62-4B1E-8819-137FF22A9864Q27026350-F12F1F85-9627-44C9-BB44-D953AE1D6425Q27311353-83805AF3-113D-491D-9E24-16988956DFBDQ28072250-A9CC8CAC-8D7F-4FC4-AF34-06A08829048CQ28073954-2EFD610D-C8FA-4C28-AE53-FD4B05C32CF3Q28388136-998001E8-4B08-43FB-AB02-42822EDF84CBQ28392789-F5CD9DF2-5C2D-4AEC-91FD-667F27A56CB3Q33647461-507B13FF-88D9-4A45-9B07-93F2FF513668Q33769787-297DE60F-D297-44E9-B63E-5116C3D063C9Q33919042-32015816-A01D-4C76-8EF4-6B2BA3B38BACQ34076206-7FE6F88E-26D7-4F55-8699-A5BAEFB2907BQ34099222-4A350F13-3AE6-4483-ABFD-B4431080C007Q34163714-E8F894D5-ABD1-4023-997C-234F0968D044Q34408378-99946F35-A877-44A0-8824-97F32EE15E73Q34486611-88F9EDE1-D0BF-4419-B76B-D6FFD32F2BA1Q34569654-3BA3A6C1-EE46-48E9-B03D-7E85211B5D78Q34627615-CE128060-B658-49B8-9CD5-2BE30F0EA74DQ34706174-5A5B15B0-8072-4019-9B63-41217ECE3EA7Q34924330-C3C5BCC5-B7E3-4677-8254-FAAE021834CCQ35077723-A3DB659D-91E9-4017-955C-1AB45483FAE8Q35083117-790A7C94-2FF1-41E3-A0F1-9052EF29D94BQ35155498-5CAFA532-B6BC-47F1-9EF5-41F87811DAAAQ35165797-97C34733-07F1-4B8B-84B3-13CFFB6C595CQ35200879-DB06033D-C7B2-4AD8-9B7D-4249D72ECEA1Q35293080-E2B3302A-83AF-4505-9C4A-7C965387E633Q35489598-CD674CC1-3783-4C01-AB90-91B17F98BA85Q35628458-7C742840-2612-4FC9-99E2-ECADBF49BB72Q35676304-094CF646-1E9A-47DF-AA78-BEF2A01B6669Q35919804-198C58CE-48E2-40EB-A384-9EA80F105AE8Q36039728-41419DFC-D600-4F23-B3C0-1BC231A673D4Q36375553-780711EF-4931-4537-A540-256828AD90CBQ36656439-22B3A086-C6EF-418B-82D6-672645A9302DQ36711812-8FC657E9-8705-4703-AC96-E95CE7E87B7DQ36719358-77FD644F-91FB-43B9-9AE7-FD6EA958FF7EQ36727898-A9F8CF7D-1D37-4FC7-B997-A2848859502AQ36851799-DE517C20-D6A4-4FB0-B5B9-7715D8337F74
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory cytokines in acute ischemic stroke.
@en
Inflammatory cytokines in acute ischemic stroke.
@nl
type
label
Inflammatory cytokines in acute ischemic stroke.
@en
Inflammatory cytokines in acute ischemic stroke.
@nl
prefLabel
Inflammatory cytokines in acute ischemic stroke.
@en
Inflammatory cytokines in acute ischemic stroke.
@nl
P2093
P1476
Inflammatory cytokines in acute ischemic stroke
@en
P2093
Domenico Di Raimondo
Giuseppe Licata
Riccardo di Sciacca
P304
P356
10.2174/138161208786848739
P577
2008-01-01T00:00:00Z